Sean Michael Smith is Interim CFO, Prin Acct Off of Neurogene Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Aug 23 | NGNE Neurogene | Common Stock | Sell | Dispose S | No | No | 0.6184 | 1,323 | 818.14 | 21,637 |
10 Aug 23 | NGNE Neurogene | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,000 | 0.00 | 22,960 |
10 Aug 23 | NGNE Neurogene | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,000 | 0.00 | 0 |
2 Feb 23 | NGNE Neurogene | Common Stock | Sell | Dispose S | No | No | 0.5972 | 3,316 | 1.98 k | 15,960 |
1 Feb 23 | NGNE Neurogene | Common Stock | Option exercise | Acquire M | No | No | 0 | 12,500 | 0.00 | 19,276 |
1 Feb 23 | NGNE Neurogene | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 12,500 | 0.00 | 12,500 |